Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Romagnoli

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trends in Genetics : TIG|December 15, 2021
A blood drop through the pore: nanopore sequencing in hematologyNiccolò Bartalucci, Simone Romagnoli, Alessandro Maria Vannucchi
Frontiers in Genetics|September 7, 2023
Resolving complex structural variants via nanopore sequencingSimone Romagnoli, Niccolò Bartalucci, Alessandro Maria Vannucchi
Clinical Chemistry|October 25, 2019
Long Reads, Short Time: Feasibility of Prenatal Sample Karyotyping by Nanopore Genome SequencingNiccolò Bartalucci, Simone Romagnoli, Elisa Contini, et al.
Blood Advances|April 23, 2021
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNsManjola Balliu, Laura Calabresi, Niccolò Bartalucci, et al.
Blood Advances|January 12, 2022
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia veraPaola Guglielmelli, Giacomo Coltro, Francesco Mannelli, et al.
Biomarker Research|November 13, 2021
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2Simone Romagnoli, Niccolò Bartalucci, Francesca Gesullo, et al.
American Journal of Hematology|July 7, 2022
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlatesGiuseppe G Loscocco, Paola Guglielmelli, Francesco Mannelli, et al.
Blood Advances|August 11, 2020
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic featuresGiacomo Coltro, Giada Rotunno, Lara Mannelli, et al.
Cell Death & Disease|December 22, 2025
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcomaGiulia Petroni, Federico Scolari, Guido Scoccianti, et al.
American Journal of Hematology|July 3, 2023
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasmsLaura Calabresi, Chiara Carretta, Simone Romagnoli, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trends in Genetics : TIG|December 15, 2021
A blood drop through the pore: nanopore sequencing in hematologyNiccolò Bartalucci, Simone Romagnoli, Alessandro Maria Vannucchi
Frontiers in Genetics|September 7, 2023
Resolving complex structural variants via nanopore sequencingSimone Romagnoli, Niccolò Bartalucci, Alessandro Maria Vannucchi
Clinical Chemistry|October 25, 2019
Long Reads, Short Time: Feasibility of Prenatal Sample Karyotyping by Nanopore Genome SequencingNiccolò Bartalucci, Simone Romagnoli, Elisa Contini, et al.
Blood Advances|April 23, 2021
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNsManjola Balliu, Laura Calabresi, Niccolò Bartalucci, et al.
Blood Advances|January 12, 2022
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia veraPaola Guglielmelli, Giacomo Coltro, Francesco Mannelli, et al.
Biomarker Research|November 13, 2021
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2Simone Romagnoli, Niccolò Bartalucci, Francesca Gesullo, et al.
American Journal of Hematology|July 7, 2022
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlatesGiuseppe G Loscocco, Paola Guglielmelli, Francesco Mannelli, et al.
Blood Advances|August 11, 2020
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic featuresGiacomo Coltro, Giada Rotunno, Lara Mannelli, et al.
Cell Death & Disease|December 22, 2025
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcomaGiulia Petroni, Federico Scolari, Guido Scoccianti, et al.
American Journal of Hematology|July 3, 2023
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasmsLaura Calabresi, Chiara Carretta, Simone Romagnoli, et al.
Pageof 2